000910745 001__ 910745
000910745 005__ 20221219115107.0
000910745 0247_ $$2doi$$a10.1007/s00259-019-04562-7
000910745 0247_ $$2ISSN$$a0340-6997
000910745 0247_ $$2ISSN$$a1432-105X
000910745 0247_ $$2ISSN$$a1619-7070
000910745 0247_ $$2ISSN$$a1619-7089
000910745 0247_ $$2Handle$$a2128/32632
000910745 0247_ $$2pmid$$a31667539
000910745 0247_ $$2WOS$$aWOS:000502971900020
000910745 037__ $$aFZJ-2022-04115
000910745 082__ $$a610
000910745 1001_ $$0P:(DE-HGF)0$$avan Eimeren, Thilo$$b0$$eCorresponding author
000910745 245__ $$aFrom molecules to system failure: translational frontiers of multimodal imaging in neurodegenerative diseases
000910745 260__ $$aHeidelberg [u.a.]$$bSpringer-Verl.$$c2019
000910745 3367_ $$2DRIVER$$aarticle
000910745 3367_ $$2DataCite$$aOutput Types/Journal article
000910745 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1668667937_3654
000910745 3367_ $$2BibTeX$$aARTICLE
000910745 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000910745 3367_ $$00$$2EndNote$$aJournal Article
000910745 520__ $$aUnderstanding the molecular and neural underpinnings of neurodegenerative diseases is one of the greatest challenges in today’s health-related research. To this end, the translation of evidence from basic science (e.g., at the molecular, cellular, or animal model level) to clinical science is paramount, yet remains particularly hard to achieve. Simultaneously, the plethora of evidence for the clinical utility of molecular imaging has not yet lead to a sufficiently available and standardized use in clinical practice and there is a critical need of a science-to-guidelines transition of these techniques. Both tasks demand an iterative, multi-disciplinary, highly collaborative approach. Following this formula, we started a biannual symposium—called “Multimodal Imaging in Neurodegeneration Cologne,” or short MINC—specifically dedicated to bridge translational gaps in particularly topical areas of research in neurodegenerative diseases. The MINC symposium in October 2018 was focused on five topics: the cause and effect of cerebral protein aggregation pathologies (beta-amyloid, tau, and alpha-synuclein), the various facets of neuroinflammation in neurodegenerative diseases, non-dopaminergic transmitter dysfunction in Parkinson’s disease, and the development of proteinaceous agents for molecular PET imaging and for therapy. The great success of this meeting was largely due to the gathering and interaction of scientist from various disciplines who would not usually meet at their respective science meetings. The 2 days of talks and discussions by experts in various fields from basic to clinical science and imaging yielded many intriguing insights. We have asked teams of participants of the meeting to summarize the main insights from this meeting. This resulted in three key chapters, which are outlined below and discussed in greater depth in three papers, which are published in this issue. We are extremely grateful to the Deutsche Forschungsgemeinschaft (DFG) for funding the MINC symposium (EI 892/5–1) and to the European Journal of Nuclear Medicine and Molecular Imaging for publishing these major outcomes of the MINC symposium as three separate publications in this issue.
000910745 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000910745 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000910745 7001_ $$0P:(DE-Juel1)177611$$aDrzezga, Alexander$$b1
000910745 773__ $$0PERI:(DE-600)2098375-X$$a10.1007/s00259-019-04562-7$$gVol. 46, no. 13, p. 2816 - 2818$$n13$$p2816 - 2818$$tEuropean journal of nuclear medicine and molecular imaging$$v46$$x0340-6997$$y2019
000910745 8564_ $$uhttps://juser.fz-juelich.de/record/910745/files/From%20molecules%20to%20system%20failure.pdf$$yOpenAccess
000910745 909CO $$ooai:juser.fz-juelich.de:910745$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Multimodal Neuroimaging Group, Department of Nuclear Medicine, University of Cologne, Cologne, Germany$$b0
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a German Center for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany$$b0
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-HGF)0$$a Department of Neurology, University of Cologne, Cologne, Germany$$b0
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a Multimodal Neuroimaging Group, Department of Nuclear Medicine, University of Cologne, Cologne, Germany$$b1
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a German Center for Neurodegenerative Diseases (DZNE), Bonn-Cologne, Germany$$b1
000910745 9101_ $$0I:(DE-HGF)0$$6P:(DE-Juel1)177611$$a Molecular Organization of the Brain, Institute of Neuroscience and Medicine (INM-2), Research Center Jülich, Jülich, Germany$$b1
000910745 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)177611$$aForschungszentrum Jülich$$b1$$kFZJ
000910745 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000910745 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J NUCL MED MOL I : 2019$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-02-02$$wger
000910745 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000910745 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bEUR J NUCL MED MOL I : 2019$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-02
000910745 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-02
000910745 920__ $$lyes
000910745 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000910745 980__ $$ajournal
000910745 980__ $$aVDB
000910745 980__ $$aUNRESTRICTED
000910745 980__ $$aI:(DE-Juel1)INM-2-20090406
000910745 9801_ $$aFullTexts